Breast Reconstruction Market Size, Share, Industry, Forecast and outlook (2024-2031)

Breast Reconstruction Market is segmented By Product Type (Implants, Tissue Expander, Acellular Dermal Matrix), By Shape (Round Shape, Anatomical Shape), By Placement (Dual Plane Insertion, Subglandular Insertion, Submuscular Insertion), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.

Breast Reconstruction Market Overview

The global breast reconstruction market reached USD 574.33 million in 2022 and is projected to witness lucrative growth by reaching up to USD 934.30 million by 2030. The breast reconstruction market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030). Technological advancements in breast reconstruction surgery have led to the development of innovative products and procedures that offer better outcomes for patients. For example, 3D printing technology is being used to create customized breast implants that fit the patient's body shape and size more accurately.  Due to the rise in breast cancer procedures, the availability of breast-restoration options, and increased knowledge of breast reconstruction, breast reconstruction is projected to increase. After breast cancer treatments like lumpectomies, mastectomies, or other congenital impairments, breast reconstruction is performed, increasing the cosmetic appeal and promoting the confidence of women. Thus, above-mentioned factors boosts the breast reconstruction market.

Breast Reconstruction Market Scope and Summary

Breast Reconstruction Market Dynamics and Trends

The Increasing Prevalence of Breast Cancer is Boosting the Global Breast Reconstruction Market Growth.

The market is being driven by an increase in breast cancer incidence. For instance, according to Breast Cancer Organization, every year in the United States, breast cancer accounts for around 30% of all new cancer diagnoses among women. In addition to 50,000 new cases of non-invasive (in situ) breast cancer, an estimated 280,000 new cases of invasive breast cancer in women are anticipated to be detected in the United States in 2022. 

In 2022, it's anticipated that 3,000 new cases of invasive breast cancer would be identified in men. About 1 in 800 men will develop breast cancer in their lifetime. In the U.S., there are more than 4 million women who have a history of breast cancer as of January 2022. Women who have completed treatment as well as those who are presently receiving it are included. As a result, the need for breast reconstruction has increased globally. Thus, from the above factors, the market is expected to drive in the forecast period.

The High Cost of Breast Surgical Procedures is Expected to Hamper the Market Growth.

In general, the cost of breast reconstruction surgery ranges from USD 25,000 to USD 50,000, or even more, for each breast, and from USD 50,000 to USD 100,000 for both. Additionally, the introduction of numerous early-stage breast cancer image detection tests, such as mammography, tomosynthesis, xero-mammography, galactography, breast MRI, scintimammography, elastography, and breast biopsy, will limit the growth of the market as fewer individuals will undergo surgical procedures for breast reconstruction.

Breast Reconstruction Market Segmentation Analysis

The global breast reconstruction market is segmented based on product type, shape, placement,  end users, and region.

The Implants Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period.

The implants segment accounted for the biggest market share accounting for approximately 60% of the breast reconstruction market in 2022, due to the increasing prevalence of breast cancer cases & breast reconstruction procedures and the increase in demand for silicone & saline breast implants; increasing Product Type launches and FDA approvals are the factors to drive the market segment.

For instance, on April 2022, Ideal Implant Incorporated launched an improved Generation 2 implant. The Generation 2 structured saline implants are made in accordance with very exacting specifications. The Gen 2 IDEAL IMPLANT has the same natural feel as silicone gel implants thanks to the use of innovative, cutting-edge robotic manufacturing technology to create shells with more consistent thicknesses. 

Additionally, even at the smallest fill volume, the implant does not wrinkle or ripple when it is held upright. The market segment thus held the biggest market share during the predicted period as a result of the aforementioned factors.

Source: DataM Intelligence Analysis (2023)

Breast Reconstruction Market Geographical Share

North America Holds a Dominant Position in the Global Breast Reconstruction Market.

North America is estimated to hold about 42% of the total market share throughout the forecast period. The increasing prevalence of breast cancer, product launches by the market players, advancement in breast implants, FDA product approvals, and rising awareness of breast reconstruction among people are the factors expecetd to drive the region's growth in the forecast period.

For instance, on October 13, 2022, The Plastic Surgery Foundation (PSF) will now move forward as the sponsor of a prospective, multicenter observational trial examining the effects of the acellular dermal matrix (ADM) and surgical mesh in implant-based breast reconstruction after acquiring approval from the U.S. Food and Drug Administration (FDA) for its Investigational Device Exemption (IDE) Shape.

And on March 24, 2022, the smooth surface, High-Strength Cohesive (HSC and HSC+) silicone gel breast implants produced by Sientra, Inc., a medical aesthetics firm dedicated to improving lives through the advancement of plastic surgery, have been given approval by Health Canada. The breast reconstruction market in North America is anticipated to expand due to the rising incidence of breast cancer and the growing attention of industry players in this region. 

Breast Reconstruction Companies and Competitive Landscape

The major global players in the market include Allergan Plc, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion, and Mentor Worldwide LLC, among others.

COVID-19 Impact on Breast Reconstruction Market

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global breast reconstruction market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials are anticipated to have little influence over the global breast reconstruction market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact positively the global breast reconstruction market owing to AI examining photos to identify breast masses, segment breast masses, determine breast density, and determine cancer risk. Since breast masses are a frequent finding in breast cancer patients, CAD's most crucial step is to perform a breast exam.

Key Developments

• On October 22, 2021, AbbVie, an implant manufacturer, produces a campaign to showcase reconstruction possibilities. With its new "Power of You" campaign, the breast implant manufacturer hopes to change that. The initiative honors patients' bravery and inner fortitude while educating them on their options for breast reconstruction.
• On April 06, 2023, breast implants will be bioprinted by CollPlant and Stratasys. The agreement's main goal is to use Stratasys' bioprinting technology to produce industrial-scale CollPlant Biotechnologies' regenerative breast implants.
• On May 17, 2022, an innovative Nipple Areola Complex (NAC) Reconstruction Implant called FixNip NRI was introduced by GC Aesthetics, Inc. (GCA), a privately held medical technology firm offering Healthcare Aesthetic Solutions. The solution to a well-known clinical need of thousands of women globally is this outstanding medical equipment. The nipple-areola complex has been attempted to be rebuilt using a number of surgical methods up until this point, but none have offered a long-term attractive answer.

Why Purchase the Report?

• To visualize the global breast reconstruction market segmentation based on product type, shape, placement, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of breast reconstruction market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in Excel consisting of key product types of all the major players.

The global breast reconstruction market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies